about
Cord blood banking activity in Iran National Cord Blood Bank: a two years experience.α:Non-α and Gγ:Aγ globin chain ratios in thalassemia intermedia patients treated with hydroxyurea.Blood donor incentives: A step forward or backwardChildhood physical abnormalities following paternal exposure to sulfur mustard gas in Iran: a case-control study.Transfusion-transmitted infections among multitransfused patients in Iran: a review.Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes.Improving availability and affordability of plasma-derived medicines.Full genome characterization of hepatitis B virus strains from blood donors in Iran.Human amniotic epithelial cells induce apoptosis of cancer cells: a new anti-tumor therapeutic strategy.Seroprevalence of hepatitis C virus: the first population-based study from Iran.Secular trends in the national and provincial births of new thalassemia cases in Iran from 2001 to 2006.An update on the prevalence of glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Tehran neonates.Detection of malaria infection in blood transfusion: a comparative study among real-time PCR, rapid diagnostic test and microscopy: sensitivity of Malaria detection methods in blood transfusion.Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007.Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.A comparison between recombinant activated factor VII (Aryoseven) and Novoseven in patients with congenital factor VII deficiency.A Comparison of Efficacy Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Hereditary FVIII Deficiency With Inhibitor.Factor XIII deficiency in south-east Iran.Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience.Blood donation and donor recruitment in Iran from 1998 through 2007: ten years' experience.A change in standard of minimum hemoglobin for male blood donors in Iran.Serum-free cryopreservation of human amniotic epithelial cells before and after isolation from their natural scaffold.Maternal Ramadan fasting and neonatal health.Inhibition of HSP90 could be possible mechanism for anti-cancer property of amniotic membrane.Umbilical bleeding: a presenting feature for congenital afibrinogenemia.Estimating Blood Transfusion Requirements in Preparation for a Major Earthquake: The Tehran, Iran StudyEffects of CXCR1 and CXCR2 inhibition on expansion and differentiation of umbilical cord blood CD133+ cells into megakaryocyte progenitor cellsThalassemia in Iran: epidemiology, prevention, and managementThe IVS-II-1 (G-->a) beta0-thalassemia mutation in cis with HbA2-Troodos [delta116(G18)Arg-->Cys (CGC-->TGC)] causes a complex prenatal diagnosis in an Iranian familyClassification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric methodSingle-donor fibrin sealant for repair of urethrocutaneous fistulae following multiple hypospadias and epispadias repairsPlatelet growth factors suppress ex vivo expansion and enhance differentiation of umbilical cord blood CD133+ stem cells to megakaryocyte progenitor cellsMegakaryocytic differentiation of CD133+ hematopoietic stem cells by down-regulation of microRNA-10a
P50
Q33456140-19B6404F-F639-45B4-8A8B-974E88762813Q33628874-1944DA40-070C-4037-88EA-8B17432B35E9Q33760705-BF9C88ED-66C6-4D02-AC3B-3648E8DB6BCAQ34049573-A66D8C50-A137-46D2-8A38-8B5EB2B1075EQ37027631-967DC018-1E7B-48DA-965A-E66C9585E72DQ37261934-F0024373-80DB-4797-AC74-49D2AD44AC83Q37688404-2FC03FEB-2A76-4A40-816E-420BC7822753Q39018089-8922256E-1C25-4463-8290-E820DC539B04Q39082596-B78861D5-5A8B-482F-BD38-89EC20EA32AAQ39886309-23A73375-F457-4D00-B462-6AF912D831C4Q44229657-5863725C-9996-4342-BB72-5E7F078CBB19Q44769813-ACA525F6-AD96-4191-9C7F-76A635B85D40Q44859726-3A16FDD4-1B2E-42E4-AB60-D2A9A60DFF37Q45381881-5B14356E-C922-4579-8459-090EF58C7042Q45383598-CBF34E63-8E61-4E10-B772-7C629F3569FBQ45863434-56373845-2086-43FC-BB80-EBE34D571E24Q45869626-06A2E3C3-BFF2-45AA-896E-3C4258D645CDQ45877738-16B8BD91-D3BC-44C5-9360-6E33E78DEC5FQ45884375-77C964EC-C9E0-4215-86BF-D91031B56776Q49118659-21B5DCA4-38E1-4958-9D4F-500410CC6C87Q50906722-39478F5D-569E-4D24-9B11-E6CBD1144529Q50983213-78431236-270D-4EC3-BE5F-36F38A9821F9Q51527810-04166624-B568-4243-96FB-EE205E15EBE9Q53089401-8C8C962A-FAC9-44AD-B8FB-C781CCEF7FFCQ53332208-7BC8466F-164F-4227-BE12-149425A14A04Q57073416-B3F3F0AB-FCD4-413E-B3E7-9778D4B56CF1Q60981463-9C027DBE-FD8F-40AA-AE54-4318DA2559BEQ80111736-56B74D80-BBD2-4CEE-A661-C4CB9E90E6D8Q82048251-58B783B0-A9A0-4B33-B6CA-803429D6E8F0Q83990267-4B441F24-1D03-4686-BC9B-7BE8161F315DQ84571992-9C5470C3-5913-419B-915B-3341DFF91E65Q85054280-0D792AD3-BBCE-43CA-8475-49A40107440DQ85900597-032CA6AE-71DF-47CE-AD73-8D4F13C59EEE
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Hassan Abolghasemi
@ast
Hassan Abolghasemi
@en
Hassan Abolghasemi
@es
Hassan Abolghasemi
@nl
Hassan Abolghasemi
@sl
type
label
Hassan Abolghasemi
@ast
Hassan Abolghasemi
@en
Hassan Abolghasemi
@es
Hassan Abolghasemi
@nl
Hassan Abolghasemi
@sl
altLabel
abolghasemi h
@en
abolghasemi hasan
@en
abolghasemi hassan
@en
abolghassemi h
@en
abolghassemi hassan
@en
hasan abolghasemi
@en
hassan abolghassemi
@en
prefLabel
Hassan Abolghasemi
@ast
Hassan Abolghasemi
@en
Hassan Abolghasemi
@es
Hassan Abolghasemi
@nl
Hassan Abolghasemi
@sl
P106
P21
P31
P496
0000-0001-6920-5029